Correction: Inotuzumab ozogamicin in pediatric patients with relapsed/refractory acute lymphoblastic leukemia.
Bhojwani D, Sposto R, Shah NN, Rodriguez V, Yuan C, Stetler-Stevenson M, O'Brien MM, McNeer JL, Quereshi A, Cabannes A, Schlegel P, Rossig C, Dalla-Pozza L, August K, Alexander S, Bourquin JP, Zwaan M, Raetz EA, Loh ML, Rheingold SR.
Bhojwani D, et al.
Leukemia. 2019 Apr;33(4):1061-1062. doi: 10.1038/s41375-019-0426-8.
Leukemia. 2019.
PMID: 30842605
Free PMC article.
We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwarkar and Jayashree Motwani, Birmingham Women's and Children's Hospital, UK; Kelly Malone, Children's Hospital of Colorado, USA; Mylene …
We thank the research coordinators and following physicians at pediatric cancer centers for contributing data to this project: Prashant Hiwa …